Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anders Kjellman, Søren Friis, Fredrik Granath, Ove Gustafsson, Henrik Toft Sørensen & Olof Akre. (2013) Treatment with finasteride and prostate cancer survival. Scandinavian Journal of Urology 47:4, pages 265-271.
Read now
Read now
Michael Borre, Rune Erichsen, Lars Lund, Erik Højkjær Larsen, Mette Nørgaard & Jacob Bonde Jacobsen. (2011) Survival of prostate cancer patients in central and northern Denmark, 1998–2009. Clinical Epidemiology 3:sup1, pages 41-46.
Read now
Read now
Lars Lund, Jacob Jacobsen, Michael Borre, Erik Højkær Larsen, Peder H. Graversen, Henrik Toft Sørensen, Mette Nørgaard, Lars Lund, Jacob Jacobsen, Michael Borre, Erik Højkær Larsen, Peder H. Graversen, Henrik Toft Sørensen & Mette Nørgaard. (2007) Improved survival of patients with prostate cancer in northern Denmark, 1985–2004. Scandinavian Journal of Urology and Nephrology 41:4, pages 308-313.
Read now
Read now
Articles from other publishers (16)
Sanny Kappen, Verena Jürgens, Michael H. Freitag & Alexander Winter. (2021) Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey. Frontiers in Oncology 11.
Crossref
Crossref
J. Panach-Navarrete, A. Gironés-Montagud, E. Sánchez-Cano, C. Doménech-Pérez & J.M. Martínez-Jabaloyas. (2017) Uso del antígeno prostático específico en atención primaria (PSA). SEMERGEN - Medicina de Familia 43:3, pages 189-195.
Crossref
Crossref
S. Lebentrau, M. May, O. Maurer, M. Schostak, M. Lehsnau, T. Ecke, S. Al-Dumaini, S. Hallmann, A.M. Ahmed, V. Braun, A. Haferkamp, R.M. Bauer, C.G. Stief, D. Baumunk, B. Hoschke, H.-P. Braun, C. Schäfer, M. Hipp, J. Maurer, K.-P. Braun, I. Wolff, S. Brookman-May & C. Gilfrich. (2014) PSA-basierte Früherkennung des Prostatakarzinoms durch den HausarztRates of prostate-specific antigen testing for early detection of prostate cancer. Der Urologe 53:5, pages 715-724.
Crossref
Crossref
Christian Gilfrich, Matthias May, Kay-Patrick Braun, Steffen Lebentrau, Mike Lehsnau, Thorsten Ecke, Kurt J.G. Schmailzl, Salah Al-Dumaini, Steffen Hallmann, Ali M. Ahmed, Julia Maurer, Thomas Karl, Vittoria Braun, Axel Haferkamp, Sabine Brookman-May, Ricarda M. Bauer, Christian G. Stief, Bernd Hoschke, Odilo Maurer & Ingmar Wolff. (2014) Evaluating the Use of Prostate-Specific Antigen as an Instrument for Early Detection of Prostate Cancer beyond Urologists: Results of a Representative Cross-Sectional Questionnaire Study of General Practitioners and Internal Specialists. Urologia Internationalis 93:2, pages 160-169.
Crossref
Crossref
Kasper Jessen, Jens Søndergaard, Pia Veldt Larsen & Janus Laust Thomsen. (2013) Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs. International Journal of Family Medicine 2013, pages 1-6.
Crossref
Crossref
Saskia Van der Meer, Sabine AM Löwik, Willem H Hirdes, Rien M Nijman, Klaas Van der Meer, Josette EHM Hoekstra-Weebers & Marco H Blanker. (2012) Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review. BMC Family Practice 13:1.
Crossref
Crossref
Maria Frånlund, Sigrid Carlsson, Johan Stranne, Gunnar Aus & Jonas Hugosson. (2012) The absence of voiding symptoms in men with a prostate‐specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial. BJU International 110:5, pages 638-643.
Crossref
Crossref
Rafael Marcos-Gragera, Diego Salmerón, Isabel Izarzugaza, Eva Ardanaz, Bernat-Carles Serdà, Nerea Larrañaga, Erkuden San Román, Carmen Navarro & María-Dolores Chirlaque. (2012) Trends in prostate cancer survival in Spain: results from population-based cancer registries. Clinical and Translational Oncology 14:6, pages 458-464.
Crossref
Crossref
Isabelle Vedel, Martine T.E. Puts, Michele Monette, Johanne Monette & Howard Bergman. (2011) The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review. Journal of Geriatric Oncology 2:3, pages 161-176.
Crossref
Crossref
KASPER DRIMER BERG, BIRGITTE GRØNKÆR TOFT, MARTIN ANDREAS RØDER, KLAUS BRASSO, BEN VAINER & PETER IVERSEN. (2011) Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re‐evaluation. APMIS 119:4-5, pages 239-246.
Crossref
Crossref
M. L. Eisenberg, Y. Park, L. A. Brinton, A. R. Hollenbeck & A. Schatzkin. (2010) Fatherhood and incident prostate cancer in a prospective US cohort. International Journal of Epidemiology 40:2, pages 480-487.
Crossref
Crossref
Arduino Verdecchia, Stefano Guzzinati, Silvia Francisci, Roberta De Angelis, Freddie Bray, Claudia Allemani, Andrea Tavilla, Mariano Santaquilani & Milena Sant. (2009) Survival trends in European cancer patients diagnosed from 1988 to 1999. European Journal of Cancer 45:6, pages 1042-1066.
Crossref
Crossref
Lars Lund, Michael Borre, Jacob Jacobsen, Henrik Toft Sørensen & Mette Nørgaard. (2008) Impact of Comorbidity on Survival of Danish Prostate Cancer Patients, 1995–2006: A Population-Based Cohort Study. Urology 72:6, pages 1258-1262.
Crossref
Crossref
Monique J. Roobol. (2008) Algorithms, nomograms and the detection of indolent prostate cancer. World Journal of Urology 26:5, pages 423-429.
Crossref
Crossref
Christine Bouchardy, Gerald Fioretta, Elisabetta Rapiti, Helena Maria Verkooijen, Charles Henry Rapin, France Schmidlin, Raymond Miralbell & Roberto Zanetti. (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer 123:2, pages 421-429.
Crossref
Crossref
John Pendleton, Robert Whit Curry, A.l.i. Kaserian, Myron Chang, Satoshi Anai, Kogenta Nakamura, Phillip Abdoush & Charles J. Rosser. (2008) Knowledge and Attitudes of Primary Care Physicians Regarding Prostate Cancer Screening. Journal of the National Medical Association 100:6, pages 666-673.
Crossref
Crossref